Investor problems have brought about a selloff in clinical unit makers, sending iShares US Health care Products exchange-traded fund down 7 per cent this yr. Fund managers might still be concerned about investing in shares perceived to become Amongst the “GLP-1 losers,” claimed HSBC analyst Rajesh Kumar.This can be attributed to many things, su